T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$1.66B |
| 2 |
KLA
KLAC
|
+$1.39B |
| 3 |
T-Mobile US
TMUS
|
+$1.38B |
| 4 |
Eli Lilly
LLY
|
+$1.37B |
| 5 |
CSX Corp
CSX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.2B |
| 2 |
Microsoft
MSFT
|
+$3.24B |
| 3 |
Amazon
AMZN
|
+$2.75B |
| 4 |
Netflix
NFLX
|
+$2.53B |
| 5 |
Apple
AAPL
|
+$2.48B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.66% |
| 2 | Financials | 11.78% |
| 3 | Healthcare | 11.44% |
| 4 | Consumer Discretionary | 10.75% |
| 5 | Communication Services | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1351
Canadian Pacific Kansas City
CP
$82.6B
| $5.44M | ﹤0.01% |
73,913
-22,833
| -24% | -$1.68M |
|
1352
iShares MSCI Global Gold Miners ETF
RING
$2.4B
| $5.43M | ﹤0.01% |
+73,724
| New | +$4.98M |
|
1353
Prosperity Bancshares
PB
$8.95B
| $5.42M | ﹤0.01% |
78,494
+3,614
| +5% | +$244K |
|
1354
United Bankshares
UBSI
$6.66B
| $5.41M | ﹤0.01% |
140,932
+3,911
| +3% | +$146K |
|
1355
First American
FAF
$7.56B
| $5.38M | ﹤0.01% |
87,530
+3,794
| +5% | +$238K |
|
1356
iShares Convertible Bond ETF
ICVT
$7.64B
| $5.38M | ﹤0.01% |
54,560
+11,502
| +27% | +$1.16M |
|
1357
Coca-Cola Femsa
KOF
$23.1B
| $5.37M | ﹤0.01% |
56,722
| – | – |
|
1358
Albertsons Companies
ACI
$5.83B
| $5.37M | ﹤0.01% |
312,595
+13,137
| +4% | +$234K |
|
1359
Kyndryl
KD
$3.04B
| $5.33M | ﹤0.01% |
200,486
+9,529
| +5% | +$258K |
|
1360
STAG Industrial
STAG
$7.12B
| $5.29M | ﹤0.01% |
143,775
+7,351
| +5% | +$279K |
|
1361
Brady Corp
BRC
$4.48B
| $5.28M | ﹤0.01% |
67,339
+2,358
| +4% | +$183K |
|
1362
iShares Russell 1000 ETF
IWB
$50.5B
| $5.28M | ﹤0.01% |
14,136
| – | – |
|
1363
Interface
TILE
$2.23B
| $5.25M | ﹤0.01% |
188,109
+8,359
| +5% | +$228K |
|
|
TXNM
1364
TXNM Energy Inc
TXNM
$5.91B
| $5.18M | ﹤0.01% |
88,027
+3,567
| +4% | +$206K |
|
|
JHG
1365
DELISTED
Janus Henderson
JHG
| $5.18M | ﹤0.01% |
108,851
+3,613
| +3% | +$160K |
|
1366
News Corp Class B
NWS
$17.7B
| $5.18M | ﹤0.01% |
174,691
+10,992
| +7% | +$328K |
|
1367
Amkor Technology
AMKR
$14.3B
| $5.17M | ﹤0.01% |
130,970
+50,015
| +62% | +$1.78M |
|
1368
Hanmi Financial
HAFC
$956M
| $5.16M | ﹤0.01% |
190,917
+20,733
| +12% | +$555K |
|
1369
Home BancShares
HOMB
$6.23B
| $5.16M | ﹤0.01% |
185,687
+5,432
| +3% | +$151K |
|
1370
MGIC Investment
MTG
$6.29B
| $5.16M | ﹤0.01% |
176,508
+2,155
| +1% | +$60.5K |
|
1371
Alaska Air
ALK
$5.3B
| $5.16M | ﹤0.01% |
102,509
+4,247
| +4% | +$196K |
|
1372
Amalgamated Financial
AMAL
$1.53B
| $5.13M | ﹤0.01% |
160,243
-29,124
| -15% | -$847K |
|
1373
Monarch Casino & Resort
MCRI
$2.22B
| $5.08M | ﹤0.01% |
53,032
+2,610
| +5% | +$251K |
|
1374
Black Hills Corp
BKH
$5.64B
| $5.03M | ﹤0.01% |
72,465
+3,742
| +5% | +$252K |
|
1375
Essential Properties Realty Trust
EPRT
$6.62B
| $5.02M | ﹤0.01% |
169,386
-390,526
| -70% | -$11.9M |
|
Similar funds
T. Rowe Price Associates's Q4 2025 Portfolio in Review
As of Q4 2025, T. Rowe Price Associates held 3,154 positions worth $927B, down 0.78% from $935B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
T. Rowe Price Associates's Q4 2025 filing shows 113 new, 1,841 increased, 860 reduced and 65 closed positions. Its largest new stake was Medline Inc: 7,325,104 shares worth $308M. The largest sale was NVIDIA, an estimated $4.2B.
By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 36% a quarter earlier, followed by Financials and Healthcare.
- T. Rowe Price Associates's largest Q4 2025 buy was Medline Inc: 7,325,104 shares worth $308M.
- T. Rowe Price Associates added most to Lam Research in Q4 2025, an estimated $1.66B increase.
- T. Rowe Price Associates's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $4.2B.
- T. Rowe Price Associates fully exited Akero Therapeutics in Q4 2025, selling an estimated $181M.
- T. Rowe Price Associates's ten largest holdings make up 37% of its $927B portfolio in Q4 2025.
- T. Rowe Price Associates opened 113 new positions and closed 65 in Q4 2025.
- T. Rowe Price Associates's portfolio value fell 0.78% quarter-over-quarter to $927B.
Based on T. Rowe Price Associates's 13F filing for Q4 2025, filed 17 Feb 2026.